HealthQuill Articles by: HealthQuill
A supercapacitor made of cement, water, and carbon black can store large amounts of energy and may form the basis for a low-cost energy storage system, researchers said.
Climate Health Pharma

In near future you can charge electric cars on a concrete roadway: MIT

HQ Team August 1, 2023: A supercapacitor made of cement, water, and carbon black can store large amounts of energy and may form

Read More
The US medical research agency has opened enrollment for the second stage of trials to evaluate about four treatments for long-Covid-19 and plans another seven treatment tests in the near future.
Drugs Health Pharma

Enrollment for test trials to find long Covid-19 treatment starts in US

HQ Team August 1, 2023: The US medical research agency has opened enrollment for the second stage of trials to evaluate about four treatments

Read More
Quest Diagnostics, a New Jersey, US-based clinical laboratory company, has started selling the first blood testing kits for detecting Alzheimer’s disease early.
Drugs Health Pharma

Quest Diagnostics unveils direct-to-customer tests for Alzheimer’s 

HQ Team August 1, 2023: Quest Diagnostics, a New Jersey, US-based clinical laboratory company, has started selling the first blood testing kits for

Read More
Harm Reduction Therapeutics’s RiVive has become the second opioid overdose reversal drug the FDA allows without a prescription in the US.
Drugs Health Pharma

USFDA gives nod for second opioid overdose reversal drug ReVive

HQ Team July 30, 2023: A not-for-profit US company, Harm Reduction Therapeutics’s ReVive has been allowed by the FDA to market its opioid

Read More
A Tanzanian child under two years of age has been diagnosed with circulating vaccine-derived poliovirus type 2 (cVDPV2), and the WHO has rated international risk at “high” due to poor surveillance.
Drugs Health Pharma

WHO rates poliovirus detection in Tanzania as “high risk” globally 

HQ Team July 29, 2023: A Tanzanian child under two years of age has been diagnosed with circulating vaccine-derived poliovirus type 2 (cVDPV2),

Read More
Merck & Co., Inc., announced it has met one of the primary goals during a late-stage trial of its breast cancer therapy, Keytruda.
Drugs Health Pharma

Merck & Co meets breast cancer therapy goal in last-stage trials

HQ Team July 29, 2023: Merck & Co., Inc., announced it has met one of the primary goals during a late-stage trial of

Read More
Alexion, AstraZeneca Rare Disease, an arm of AstraZeneca group, has signed a $1 billion pact with Pfizer for gene therapy projects.
Drugs Health Pharma

Alexion, Pfizer sign $1 billion accord for genomic medicines

HQ Team July 29, 2023: Alexion, AstraZeneca Rare Disease, an arm of AstraZeneca group, has signed a $1 billion pact with Pfizer for

Read More
Biogen Inc., a US-based biotechnology company, will acquire Reata Pharmaceuticals for $7.3 billion to expand its neurological portfolio, according to a company statement
Drugs Health Pharma

Biogen Inc. to buy US-based Reata Pharmaceuticals for $7.3 billion

HQ Team July 29, 2023: Biogen Inc., a US-based biotechnology company, will acquire Reata Pharmaceuticals for $7.3 billion to expand its neurological portfolio,

Read More
Medicines for treating diseases such as cancer, multiple sclerosis, cardiovascular conditions, Ebola, and diabetes have been added to the WHO Essential Medicines List.
Drugs Health Pharma

Cancer, multiple sclerosis, Ebola treatments in new WHO Essential Medicines List

HQ Team July 26, 2023: Medicines for treating diseases such as cancer, multiple sclerosis, cardiovascular conditions, Ebola, and diabetes have been added to

Read More
An unusual rise in cases of Guillain-Barré Syndrome (GBS), a rare neurological disorder, has been reported from Peru, which has declared a state of national health emergency, the WHO stated.
Drugs Health Pharma

Guillain-Barré Syndrome cases rising in Peru, cause unknown

HQ Team July 26, 2023: An unusual rise in cases of Guillain-Barré Syndrome (GBS), a rare neurological disorder, has been reported from Peru,

Read More